Table 3.
Epidemiological and clinical features of colonized or infected patients
| Variable | Total N = 40 |
|---|---|
| Number of Male patients(%) | 30(75) |
| Mean Age (years) (Mean ± Standard deviation) | 52.45 ± 16.5 |
| Median length of ICU stay (days) [IQR] | 10 [5–16] |
| Patients with lenght of ICU stay ≥7 days (%) | 26(65) |
| Median duration of ICU stay prior to Colonization/infection(days) [IQR] | 6[1.5–16.5] |
| Respiratory distress | 7(17.5) |
| postoperative care | 10(25) |
| Cerebrovascular accidents | 13(32.5) |
| Severe polytrauma | 6(15) |
| Underlyning disease | N (%) |
| Diabetes | 7(17.5) |
| Chronic renal failure | 5(12.5) |
| Arterial hypertension | 6(15) |
| Chronic heart failure | 7(17.5) |
| Chronic obstructive pulmonary disease | 6(15) |
| Chronic smoking | 6(15) |
| Solid tumor | 7(17.5) |
| Invasive procedure | N (%) |
| Venous catheter | 11(27.5) |
| Arterial catheter | 4(10) |
| Urinary catheter | 26(65) |
| Mechanical ventilation | 24(60) |
| Nasogastric tube | 3(7.5) |
| Abdominal drain | 4(10) |
| Recent surgery | 4(10) |
| Parenteral nutrition | 30(77.5) |
| Dialysis | 3(7.5) |
| Septic shock N (%) | 14(76) |
| Previous antibiotic treatment N (%) | 35(87.5) |
| Amoxicillin/clavulanic acid N (%) | 10(25) |
| Ceftriaxone N (%) | 7(17.5) |
| Imipenem N (%) | 23(57.5) |
| Aminoglycosides N (%) | 19(47.5) |
| Colistin | 9(22.5) |
| Ciprofloxacin | 3(7.5) |
| Corticosteroid therapy N (%) | 19(47.5) |
| Death rate N (%) | 21(52.5) |
ICU Intensive care unit, IQR Interquartile rang